Ryan Hutchinson, M.D., is an Assistant Professor in the Department of Urology at UT Southwestern Medical Center. He practices primarily in Fort Worth at John Peter Smith Hospital and the Moncrief Medical Center.

Dr. Hutchinson holds bachelor of science degrees in biochemistry and immunology from the University of California, Los Angeles, where he graduated from the honors collegium. He earned his medical degree at Vanderbilt University.

After completing a residency in urology at Mayo Clinic Florida, he completed his fellowship in urologic oncology at UT Southwestern Medical Center. During his fellowship, he started a first-in-world tissue biobank through a collaboration between the Southwest Transplant Alliance and the basic science researchers in the Department of Urology.

Dr. Hutchinson is primarily interested in early stage novel diagnostics and therapeutics, having advised the university’s Office for Technology Development. He holds multiple patents in the space.

He is the author of more than 30 articles in peer-reviewed publications and serves as a reviewer for Urologic Oncology, Urology, Journal of Urology, and European Urology.

See More

Meet Dr. Hutchinson

Urologist in Fort Worth

Dr. Hutchinson understands that patients come first. Whether practicing at John Peter Smith, the public hospital in Fort Worth, or at the Moncrief Medical Center, he takes into account the entire picture of his patients’ lives, including their wishes and disease, in developing a care plan.

“Every patient is unique and every problem is an opportunity to give that patient the best we have to offer, based on the available evidence and our own experience with delivering high quality care,” says Dr. Hutchinson.

Dr. Hutchinson enjoys seeing a wide range of urologic diseases, however his primary research focus is in urologic malignancies and early stage novel technologies.

When he met with a promising basic science researcher, Douglas Strand, Ph.D., they identified a nationwide research problem and set out to solve it. Using novel whole organ single cell isolation techniques, the group was able to assemble the first tissue bank of true normal bladder and prostate tissue, allowing researchers in the field a previously unavailable resource. This desire to blaze new paths has motivated his other projects, including a novel gene panel to predict grade progression in bladder cancer patients and a patented dissolvable ureteral dilator to allow for less traumatic treatment of kidney stones.

See More

Education & Training
  • Medical School - Vanderbilt University School of Medicine (2006-2010)
  • Internship - Mayo Clinic College of Medicine (2010-2011), General Surgery
  • Residency - Mayo Clinic College of Medicine (2011-2015), Urology

Clinical Focus

  • Bladder Cancer
  • General Urology
  • Genitourinary Cancer
  • Kidney Cancer
  • Stones
  • Male Urology
  • Testicular Cancer

See More